Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-23 Purchase |
2020-06-25 4:33 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
500,000 | $20 | $10,000,000 | 5,392,109 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2020-07-29 9:57 pm |
N/A N/A |
Allovir Inc. | ALVR | GADICKE ANSBERT Director 10% Owner |
0 | $0 | 13,451,167 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 7:20 pm |
N/A 2030-07-23 |
iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT Director 10% Owner |
16,608 | $0 | 0 (Direct) |
View |
Ownership |
2020-07-23 7:22 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. Director 10% Owner |
0 | $0 | 5,742,220 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 4:33 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
4,892,109 | $0 | 5,392,109 (Indirect) |
View |
Ownership |
2020-06-18 9:28 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
0 | $0 | 4,892,109 (Indirect) |
View |